Skip to content
HowShorted

Spyre Therapeutics, Inc. short interest in 2026

In 2026, Spyre Therapeutics, Inc.'s disclosed short interest ran from 12.98% of shares outstanding on 15 Jan 2026 to 13.76% on 15 Sep 2026, a change of +0.78 percentage points. The year's high was 15.71% on 30 Jun 2026 and its low 12.56% on 13 Feb 2026, averaging 13.76% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 20.29 days on 30 Jan 2026. Full history: Spyre Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Spyre Therapeutics, Inc. in 2026

2026 in figures

Start of year
12.98% (15 Jan 2026)
End of year
13.76% (15 Sep 2026)
Change
+0.78 pp
High
15.71% (30 Jun 2026)
Low
12.56% (13 Feb 2026)
Average
13.76%
Highest days to cover
20.29 (30 Jan 2026)
SEC filings marked
7

Every report in 2026

Spyre Therapeutics, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202612.98%13.89
30 Jan 202612.86%20.29
13 Feb 202612.56%14.87
27 Feb 202612.71%12.4210-K filed, results (8-K)
13 Mar 202612.73%13.99
31 Mar 202613.29%11.48
15 Apr 202614.86%7.35results (8-K)
30 Apr 202614.07%10.04
15 May 202614.30%10.4410-Q filed, results (8-K)
29 May 202614.54%15.47
15 Jun 202614.53%10.83
30 Jun 202615.71%5.56
15 Jul 202614.40%9.03
31 Jul 202613.77%13.52
14 Aug 202613.33%15.9510-Q filed, results (8-K)
31 Aug 202613.45%9.69
15 Sep 202613.76%11.58

See also: Spyre Therapeutics, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.